Emma J Hamilton1,2, Wendy A Davis1, Ranita Siru2, Mendel Baba3, Paul E Norman1,4, Timothy M E Davis5. 1. Medical School, University of Western Australia, Perth, Western Australia, Australia. 2. Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Murdoch, Western Australia, Australia. 3. Podiatry Department, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia. 4. Department of Vascular Surgery, Fiona Stanley Hospital, Murdoch, Western Australia, Australia. 5. Medical School, University of Western Australia, Perth, Western Australia, Australia tim.davis@uwa.edu.au.
Abstract
OBJECTIVE: To determine whether, reflecting trends in other chronic complications, incident hospitalization for diabetes-related foot ulcer (DFU) has declined over recent decades in type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants with type 2 diabetes from the community-based Fremantle Diabetes Study phases I (FDS1; 1,296 participants, mean age 64.0 years, 48.6% males, recruited 1993-1996) and II (FDS2; 1,509 participants, mean age 65.4 years, 51.8% males, recruited 2008-2011) were followed from entry to first hospitalization for/with DFU, death, or 5 years (whichever came first). Incident rate ratios (IRRs) and incident rate differences (IRDs) were calculated for FDS2 versus FDS1 overall and in 10-year age-groups. Cox proportional hazards modeling determined independent predictors of first DFU hospitalization in the combined cohort. RESULTS: Incident DFU hospitalization (95% CI) was 1.9 (0.9-3.3)/1,000 person-years in FDS1 during 5,879 person-years of follow-up and 4.5 (3.0-6.4)/1,000 person-years in FDS2 during 6,915 person-years of follow-up. The crude IRR (95% CI) was 2.40 (1.17-5.28) (P = 0.013) and IRD 2.6 (0.7-4.5)/1,000 person-years (P = 0.010). The highest IR for any age-group was 23.6/1,000 person-years in FDS2 participants aged 31-40 years. Age at diabetes diagnosis (inverse), HbA1c, insulin use, height, ln(urinary albumin/creatinine), absence of any foot pulse, previous peripheral revascularization, and peripheral sensory neuropathy (PSN) were independent predictors of incident hospitalization for/with DFU. CONCLUSIONS: Incident DFU hospitalizations complicating type 2 diabetes increased between FDS phases, especially in younger participants, and were more likely in those with PSN, peripheral arterial disease, and suboptimal glycemic control at baseline.
OBJECTIVE: To determine whether, reflecting trends in other chronic complications, incident hospitalization for diabetes-related foot ulcer (DFU) has declined over recent decades in type 2 diabetes. RESEARCH DESIGN AND METHODS: Participants with type 2 diabetes from the community-based Fremantle Diabetes Study phases I (FDS1; 1,296 participants, mean age 64.0 years, 48.6% males, recruited 1993-1996) and II (FDS2; 1,509 participants, mean age 65.4 years, 51.8% males, recruited 2008-2011) were followed from entry to first hospitalization for/with DFU, death, or 5 years (whichever came first). Incident rate ratios (IRRs) and incident rate differences (IRDs) were calculated for FDS2 versus FDS1 overall and in 10-year age-groups. Cox proportional hazards modeling determined independent predictors of first DFU hospitalization in the combined cohort. RESULTS: Incident DFU hospitalization (95% CI) was 1.9 (0.9-3.3)/1,000 person-years in FDS1 during 5,879 person-years of follow-up and 4.5 (3.0-6.4)/1,000 person-years in FDS2 during 6,915 person-years of follow-up. The crude IRR (95% CI) was 2.40 (1.17-5.28) (P = 0.013) and IRD 2.6 (0.7-4.5)/1,000 person-years (P = 0.010). The highest IR for any age-group was 23.6/1,000 person-years in FDS2 participants aged 31-40 years. Age at diabetes diagnosis (inverse), HbA1c, insulin use, height, ln(urinary albumin/creatinine), absence of any foot pulse, previous peripheral revascularization, and peripheral sensory neuropathy (PSN) were independent predictors of incident hospitalization for/with DFU. CONCLUSIONS: Incident DFU hospitalizations complicating type 2 diabetes increased between FDS phases, especially in younger participants, and were more likely in those with PSN, peripheral arterial disease, and suboptimal glycemic control at baseline.
Authors: Sridharan Raghavan; Jie Huang; Catherine Tcheandjieu; Jennifer E Huffman; Elizabeth Litkowski; Chang Liu; Yuk-Lam A Ho; Haley Hunter-Zinck; Hongyu Zhao; Eirini Marouli; Kari E North; Ethan Lange; Leslie A Lange; Benjamin F Voight; J Michael Gaziano; Saiju Pyarajan; Elizabeth R Hauser; Philip S Tsao; Peter W F Wilson; Kyong-Mi Chang; Kelly Cho; Christopher J O'Donnell; Yan V Sun; Themistocles L Assimes Journal: PLoS Genet Date: 2022-06-02 Impact factor: 6.020
Authors: Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; John W McEvoy; Robert Christenson; Elizabeth Selvin Journal: Diabetes Res Clin Pract Date: 2022-01-20 Impact factor: 5.602
Authors: Meghan B Brennan; W Ryan Powell; Farah Kaiksow; Joseph Kramer; Yao Liu; Amy J H Kind; Christie M Bartels Journal: JAMA Netw Open Date: 2022-04-01